JVMTX | SEVAX | JVMTX / SEVAX | |
Total Expense Ratio | 0.99 | 1.15 | 86% |
Annual Report Gross Expense Ratio | 1.10 | 1.19 | 92% |
Fund Existence | 12 years | 28 years | - |
Gain YTD | 11.891 | 6.466 | 184% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 24.3B | 308M | 7,890% |
Annual Yield % from dividends | 0.62 | 0.56 | 112% |
Returns for 1 year | 2.74 | -0.96 | -286% |
Returns for 3 years | 24.58 | 14.45 | 170% |
Returns for 5 years | 54.13 | 44.50 | 122% |
Returns for 10 years | 57.10 | 26.07 | 219% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FGREX | 9.20 | 0.08 | +0.88% |
Invesco Global Real Estate R6 | |||
FSMEX | 60.45 | 0.49 | +0.82% |
Fidelity Select Medical Tech and Devcs | |||
FWCGX | 73.25 | 0.34 | +0.47% |
American Funds Capital World Gr&Inc529F3 | |||
AVCNX | 18.21 | 0.01 | +0.05% |
Avantis® U.S. Small Cap Value G | |||
MBERX | 32.23 | -0.06 | -0.19% |
NYLI Balanced Class R6 |